Navigation Links
CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
Date:3/13/2008

WESTCHESTER, Ill., March 13 /PRNewswire-USNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) today released a new policy that expands continuous positive airway pressure (CPAP) therapy for Medicare patients with obstructive sleep apnea (OSA). Now Medicare beneficiaries will be able to undergo diagnosis for OSA using a home sleep test.

The new policy marks a significant departure from current Medicare coverage for CPAP and diagnosis of OSA. Experts with the American Academy of Sleep Medicine (AASM), the leading physician organization dedicated to establishing standards for patient care and promoting excellence in sleep medicine health care, education and research, are available to provide official comment on the new CMS policy and its implications for patient care and the sleep medicine field.


'/>"/>
SOURCE American Academy of Sleep Medicine
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...n of the skin that affects more than 80 percent of...tress has often been cited // as a source of acne,... Twenty-two university students participated in th...one academic examination within the time of the st...
...ertaken at Wake Forest University Baptist Medical ... signs after research in monkeys suggested //that ... fact affect heart attack severity. At an annual...se Society in Washington, D.C. today, Dr. J. Koudy...
... report more than half a million women in developi... the Partnership for Safe Motherhood and Newborn H...nd the world to ensure that a woman does not die w...eport indicates that the needs are wide-ranging - ...
...run by nurses and dieticians have been found effec...ther analysis // has shown they work only when the...esterol-lowering drugs. Researchers looked at a pr...medications from their physicians and were only “c...
Other Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2Health News:WHO acts to reduce the maternal death toll 2
(Date:9/4/2008)...Patient Identification for Targeted Therapies ...tment HUNTINGTON BEACH, Calif., and AMSTERDAM, ...rld leader in molecular cancer diagnostics,today ...nostic test that,allows physicians to quantitative...rogen receptor (ER), progesterone receptor (PR) an...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)...nd GENEVA, Sept. 3 /- Artelis SA and,...based monoclonal antibody,production with the achi...er liter. This record level was accomplished by ap...igh-performance stable Selexis CHO,production cell...ists at,Selexis SA using their proprietary Selexis...
(Date:9/3/2008)...rations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, ...FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) annou...tions to focus on commercial and late-stage produc...ecialty pharmaceutical pain management,company. Th...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 1Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 2Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 3Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 4Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 6150 Years Later House Divided Speech Still Holds Strong Message 22081 1150 Years Later House Divided Speech Still Holds Strong Message 22081 2AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 1AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 1Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 3
...- Cytogen,Corporation (NASDAQ: CYTO) reported upda...uating QUADRAMET(R) (samarium Sm-153,lexidronam in...),Millennium Pharmaceuticals, Inc.) in patients w...ts were presented today in a,poster titled, "Phase... Multiple Myeloma," by James Berenson, M.D., Medic...
...tion against,infection with virus types beyond 16 ...ine, PHILADELPHIA, June 27, 2007 /PRNewswire-First...se III study show that,CERVARIX(R), the GlaxoSmith...up to 100 percent protection against advanced prec...f human papillomavirus,types 16 and 18. The study...
Other Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: